Cloud Stocks: Guardant Seeks to Disrupt Oncology Testing
October 07, 2020 at 14:11 PM EDT
Guardant continues to expand its data library. Last quarter, it launched a real-world clinical genomic platform called GuardantINFORM to help accelerate research and development of the next generation of cancer therapeutics.
